High nuclear expression of HIF1α, synergizing with inactivation of LIMD1 and VHL, portray worst prognosis among the bladder cancer patients: association with arsenic prevalence.

Basu M, Chatterjee A, Chakraborty B, Chatterjee E, Ghosh S, Samadder S, Pal DK, Roy A, Chakrabarti J, Ghosh A, Panda CK

Open source

DOI
10.1007/s00432-021-03661-z
Published
2021 Aug
Container
Journal of cancer research and clinical oncology
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00432-021-03661-z,
  title = {High nuclear expression of HIF1α, synergizing with inactivation of LIMD1 and VHL, portray worst prognosis among the bladder cancer patients: association with arsenic prevalence.},
  author = {Basu M and Chatterjee A and Chakraborty B and Chatterjee E and Ghosh S and Samadder S and Pal DK and Roy A and Chakrabarti J and Ghosh A and Panda CK},
  year = {2021},
  journal = {Journal of cancer research and clinical oncology},
  doi = {10.1007/s00432-021-03661-z},
  url = {https://doi.org/10.1007/s00432-021-03661-z}
}

RIS

TY  - JOUR
TI  - High nuclear expression of HIF1α, synergizing with inactivation of LIMD1 and VHL, portray worst prognosis among the bladder cancer patients: association with arsenic prevalence.
AU  - Basu M
AU  - Chatterjee A
AU  - Chakraborty B
AU  - Chatterjee E
AU  - Ghosh S
AU  - Samadder S
AU  - Pal DK
AU  - Roy A
AU  - Chakrabarti J
AU  - Ghosh A
AU  - Panda CK
PY  - 2021
JO  - Journal of cancer research and clinical oncology
DO  - 10.1007/s00432-021-03661-z
UR  - https://doi.org/10.1007/s00432-021-03661-z
ER  - 

APA

M, B., A, C., B, C., E, C., S, G., S, S., DK, P., A, R., J, C., A, G., & CK, P. (2021). High nuclear expression of HIF1α, synergizing with inactivation of LIMD1 and VHL, portray worst prognosis among the bladder cancer patients: association with arsenic prevalence.. Journal of cancer research and clinical oncology. https://doi.org/10.1007/s00432-021-03661-z

Source records